Adverse effect of delayed pushing on postpartum blood loss in nulliparous women with epidural analgesia.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 24 04 2018
revised: 27 08 2018
accepted: 16 04 2020
pubmed: 5 5 2020
medline: 30 9 2020
entrez: 5 5 2020
Statut: ppublish

Résumé

To test for an association between blood loss and time until pushing (TUP) after full cervical dilation in nulliparous women with epidural analgesia. A prospective cohort study was performed at the University Hospital of Zurich between October 2015 and November 2016. Included were 228 nulliparous women with singleton pregnancy, planned vaginal delivery after 36 completed weeks of gestation, epidural analgesia, and guided active pushing. TUP was defined as the interval between full cervical dilation and initiation of active pushing. The primary outcome measure was blood loss, assessed by the postpartum decrease in hemoglobin (ΔHb), estimated blood loss, and rate of ΔHb ≥30 g/L. Associations between TUP and primary and secondary maternal and neonatal delivery outcomes were assessed using Spearman correlation, Mann-Whitney U test, Kruskal-Wallis test, or Fisher exact test, as appropriate. Longer TUP correlated significantly with increased ΔHb (ρ=0.142, P=0.033) and higher rates of ΔHb ≥30 g/l (P=0.002). Composite adverse maternal and neonatal outcomes were unaffected. On the grounds of increased maternal blood loss, and in contrast to the current International Federation of Gynecology and Obstetrics (FIGO) guideline, delayed active pushing is not recommended in nulliparous women with epidural analgesia.

Identifiants

pubmed: 32364638
doi: 10.1002/ijgo.13175
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-97

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 International Federation of Gynecology and Obstetrics.

Références

Cambic CR, Wong CA. Labour analgesia and obstetric outcomes. Br J Anaesth. 2010;105(Suppl.1):i50-60.
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 177: Obstetric Analgesia and Anesthesia. Obstet Gynecol. 2017;129:e73-89.
Kpéa L, Bonnet MP, Le Ray C, Prunet C, Ducloy-Bouthors AS, Blondel B. Initial preference for labor without neuraxial analgesia and actual use: Results from a national survey in France. Anesth Analg. 2015;121:759-766.
Fraser WD, Marcoux S, Krauss I, Douglas J, Goulet C, Boulvain M. Multicenter, randomized, controlled trial of delayed pushing for nulliparous women in the second stage of labor with continuous epidural analgesia. The PEOPLE (Pushing Early or Pushing Late with Epidural) Study Group. Am J Obstet Gynecol. 2000;182:1165-1172.
FIGO Safe Motherhood and Newborn Health (SMNH) Committee. Management of the second stage of labor. Int J Gynaecol Obstet Off Organ Int Fed Gynecol Obstet. 2012;119:111-116.
Yee LM, Sandoval G, Bailit J, et al. Maternal and neonatal outcomes with early compared with delayed pushing among nulliparous women. Obstet Gynecol. 2016;128:1039-1047.
Le Ray C, Audibert F, Goffinet F, Fraser W. When to stop pushing: Effects of duration of second-stage expulsion efforts on maternal and neonatal outcomes in nulliparous women with epidural analgesia. Am J Obstet Gynecol. 2009;201:361.e1-361.e7.
Looft E, Simic M, Ahlberg M, Snowden JM, Cheng YW, Stephansson O. Duration of second stage of labour at term and pushing time: Risk factors for postpartum haemorrhage. Paediatr Perinat Epidemiol. 2017;31:126-133.
Frey HA, Tuuli MG, Cortez S, et al. Does delayed pushing in the second stage of labor impact perinatal outcomes? Am J Perinatol. 2012;29:807-814.
Grobman WA, Bailit J, Lai Y, et al. Association of the duration of active pushing with obstetric outcomes. Obstet Gynecol. 2016;127:667-673.
Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066-1074.
Roberts CL, Torvaldsen S, Cameron CA, Olive E. Delayed versus early pushing in women with epidural analgesia: A systematic review and meta-analysis. BJOG. 2004;111:1333-1340.
Tuuli MG, Frey HA, Odibo AO, Macones GA, Cahill AG. Immediate compared with delayed pushing in the second stage of labor: A systematic review and meta-analysis. Obstet Gynecol. 2012;120:660-668.
Haslinger C, Korte W, Hothorn T, Brun R, Greenberg C, Zimmermann R. The impact of prepartum factor XIII activity on postpartum blood loss. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14795. [Epub ahead of print].
Dildy GA, Paine AR, George NC, Velasco C. Estimating blood loss: Can teaching significantly improve visual estimation? Obstet Gynecol. 2004;104:601-606.
Yoong W, Karavolos S, Damodaram M, et al. Observer accuracy and reproducibility of visual estimation of blood loss in obstetrics: How accurate and consistent are health-care professionals? Arch Gynecol Obstet. 2010;281:207-213.
Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115:1265-1272.
Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Analg. 2010;110:1368-1373.

Auteurs

Anton Fiedler (A)

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

Romana Brun (R)

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

Debora Randegger (D)

University of Zurich, Zurich, Switzerland.

Dalia Balsyte (D)

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

Roland Zimmermann (R)

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

Christian Haslinger (C)

Division of Obstetrics, University Hospital of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH